Impact of COPD in Patients with Lung Cancer and Advanced Disease Treated with Chemotherapy And/or Tyrosine Kinase Inhibitors

Overview

Journal Int J Chron Obstruct Pulmon Dis

Publisher Dove Medical Press

Specialty Pulmonary Medicine

Date 2014 Oct 23

PMID 25336937

Citations 29

Authors

Jose Luis Izquierdo

Pilar Resano

Abdulkader El Hachem

Desire Graziani

Carlos Almonacid

Ignacio M Sanchez

Affiliations

Soon will be listed here.

Abstract

While it is relatively well known that the prognosis of patients with lung cancer (LC) treated with surgery is worse in the presence of chronic obstructive pulmonary disease (COPD), it is unknown if this assessment can be extrapolated to patients with advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors. The aim of our study is to analyze the clinical characteristics and survival rates in patients with LC and COPD, and to compare these to the patients without airflow obstruction. From 471 evaluable patients, 324 (69%) were not treated with surgery due to disseminated disease (stages 3B and 4). Of them, 47.7% also had COPD. All patients were treated at the moment of diagnosis according to National Comprehensive Cancer Network guidelines with platinum-based chemotherapy or tyrosine kinase inhibitors. Kaplan-Meier curves showed no significant differences in overall survival between COPD and non-COPD patients (log-rank P=0.65). In the multivariate Cox proportional hazard model adjusting for the most relevant variables, the adjusted hazard ratio (HRadj) was statistically significant for performance status (HRadj =1.33, 95% confidence interval [CI]: 1.11-1.59; P=0.002) and clinical stage (HRadj =0.67, 95% CI: 0.50-0.89; P=0.006), but not for COPD status (HRadj =1.20, 95% CI: 0.83-1.50; P=0.46). Our conclusion is that at present, when using standard care in advanced LC (stages 3B and 4), COPD does not have a significant deleterious impact on overall survival.

Citing Articles

Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A Clinico-Pathological and Molecular Study.

Lunardi F, Nardo G, Lazzarini E, Tzorakoleftheraki S, Comacchio G, Fonzi E J Pers Med. 2024; 14(8).

PMID: 39202030 PMC: 11355616. DOI: 10.3390/jpm14080839.

Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Respiratory Disease; Interstitial Pneumonia, Chronic Obstructive Pulmonary Disease, and Tuberculosis.

Otoshi R, Ikeda S, Kaneko T, Sagawa S, Yamada C, Kumagai K Cancers (Basel). 2024; 16(9).

PMID: 38730686 PMC: 11083871. DOI: 10.3390/cancers16091734.

Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians.

Criner G, Agusti A, Borghaei H, Friedberg J, Martinez F, Miyamoto C Chronic Obstr Pulm Dis. 2022; 9(3):454-476.

PMID: 35790131 PMC: 9448004. DOI: 10.15326/jcopdf.2022.0296.

Does the Combined Use of Aspirin and Immunotherapy Result in Better Outcomes in Non-Small Cell Lung Cancer Than Immunotherapy Alone?.

Aiad M, Tahir A, Fresco K, Prenatt Z, Ramos-Feliciano K, Walia J Cureus. 2022; 14(6):e25891.

PMID: 35720783 PMC: 9190187. DOI: 10.7759/cureus.25891.

Spirometry at diagnosis and overall survival in non-small cell lung cancer patients.

Zhai T, Li Y, Brown R, Lanuti M, Gainor J, Christiani D Cancer Med. 2022; 11(24):4796-4805.

PMID: 35545892 PMC: 9761088. DOI: 10.1002/cam4.4808.

References

Sekine Y, Behnia M, Fujisawa T . Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002; 37(1):95-101. DOI: 10.1016/s0169-5002(02)00014-4. View

Battafarano R, Piccirillo J, Meyers B, Hsu H, Guthrie T, Cooper J . Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002; 123(2):280-7. DOI: 10.1067/mtc.2002.119338. View

Algar F, Alvarez A, Salvatierra A, Baamonde C, Aranda J, Lopez-Pujol F . Predicting pulmonary complications after pneumonectomy for lung cancer. Eur J Cardiothorac Surg. 2003; 23(2):201-8. DOI: 10.1016/s1010-7940(02)00719-4. View

Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F . COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax. 2004; 59(8):679-81. PMC: 1747095. DOI: 10.1136/thx.2003.018291. View

. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir. 1983; 19 Suppl 5:1-95. View

Nomura A, STEMMERMANN G, Chyou P, Marcus E, Buist A . Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis. 1991; 144(2):307-11. DOI: 10.1164/ajrccm/144.2.307. View

Rosenthal S, Curran Jr W, Herbert S, Hughes E, Sandler H, Stafford P . Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease). Cancer. 1992; 70(10):2410-7. DOI: 10.1002/1097-0142(19921115)70:10<2410::aid-cncr2820701006>3.0.co;2-4. View

Congleton J, Muers M . The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med. 1995; 89(4):291-6. DOI: 10.1016/0954-6111(95)90090-x. View

. [The surgery of bronchogenic carcinoma in Spain. A descriptive study. The Cooperative Group on Bronchogenic Carcinoma of SEPAR (GCCB-S). Sociedad Española de Neumología y Cirugía Torácica]. Arch Bronconeumol. 1995; 31(6):303-9. View

10.

Lopez-Encuentra A, Astudillo J, Cerezal J, Gonzalez-Aragoneses F, Novoa N, Sanchez-Palencia A . Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer. Eur J Cardiothorac Surg. 2005; 27(1):8-13. DOI: 10.1016/j.ejcts.2004.09.010. View

11.

Alberg A, Brock M, Samet J . Epidemiology of lung cancer: looking to the future. J Clin Oncol. 2005; 23(14):3175-85. DOI: 10.1200/JCO.2005.10.462. View

12.

McGarry R, Papiez L, Williams M, Whitford T, Timmerman R . Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005; 63(4):1010-5. DOI: 10.1016/j.ijrobp.2005.03.073. View

13.

Loganathan R, Stover D, Shi W, Venkatraman E . Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest. 2006; 129(5):1305-12. DOI: 10.1378/chest.129.5.1305. View

14.

Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J . Developing COPD: a 25 year follow up study of the general population. Thorax. 2006; 61(11):935-9. PMC: 2121175. DOI: 10.1136/thx.2006.062802. View

15.

Calverley P, Anderson J, Celli B, Ferguson G, Jenkins C, Jones P . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007; 356(8):775-89. DOI: 10.1056/NEJMoa063070. View

16.

Gomez Sebastian G, Guell Rous R, Gonzalez Valencia A, Fibla Alfara J, Estrada Salo G, Leon Gonzalez C . [Impact of a rescue program on the operability of patients with bronchogenic carcinoma and chronic obstructive pulmonary disease]. Arch Bronconeumol. 2007; 43(5):262-6. DOI: 10.1016/s1579-2129(07)60064-0. View

17.

Sekine Y, Yamada Y, Chiyo M, Iwata T, Nakajima T, Yasufuku K . Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection. Ann Thorac Surg. 2007; 84(3):946-50. DOI: 10.1016/j.athoracsur.2007.04.038. View

18.

Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589):741-50. DOI: 10.1016/S0140-6736(07)61377-4. View

19.

Choe Y, Kim S, Lee K, Lee K, Park S, Jin G . The use of PTC and RFA as treatment alternatives with low procedural morbidity in non-small cell lung cancer. Eur J Cancer. 2009; 45(10):1773-9. DOI: 10.1016/j.ejca.2009.02.016. View

20.

Chansky K, Sculier J, Crowley J, Giroux D, Meerbeeck J, Goldstraw P . The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol. 2009; 4(7):792-801. DOI: 10.1097/JTO.0b013e3181a7716e. View